Skip to main content

2 Result(s)

within Antoine Vasseur Remove this filter

and

  1. Article

    Open Access

    Fulvestrant and everolimus efficacy after CDK4/6 inhibitor: a prospective study with circulating tumor DNA analysis

    In a prospective study (NCT02866149), we assessed the efficacy of fulvestrant and everolimus in CDK4/6i pre-treated mBC patients and circulating tumor DNA (ctDNA) changes throughout therapy. Patients treated w...

    Antoine Vasseur, Luc Cabel, Caroline Hego, Wissam Takka, Olfa Trabelsi Grati… in Oncogene (2024)

    Download PDF (1872 KB) View Article

  2. No Access

    Article

    Prognostic value of CEC count in HER2-negative metastatic breast cancer patients treated with bevacizumab and chemotherapy: a prospective validation study (UCBG COMET)

    Proof of concept studies has reported that circulating endothelial cell (CEC) count may be associated with the outcome of HER2-negative metastatic breast cancer (mBC) patients treated by chemotherapy and the a...

    Antoine Vasseur, Luc Cabel, Olivier Tredan, Marion Chevrier, Coraline Dubot… in Angiogenesis (2020)